Clinical Radiology
Volume 64, Issue 7 , Pages 675-681 , July 2009

Sarcoid-like reaction to malignancy on whole-body integrated 18F-FDG PET/CT: prevalence and disease pattern

  • F.U. Chowdhury

      Affiliations

    • Departments of Radiology and Nuclear Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK
    • Corresponding Author InformationGuarantor and correspondent: F. U. Chowdhury, Department of Radiology and Nuclear Medicine, Leeds Teaching Hospitals NHS Trust, Bexley Wing, Level 1, Beckett Street, Leeds LS9 7TF, UK. Tel.: +44 113 2068260/212; fax: +44 113 2068228.
    • ,
  • F. Sheerin

      Affiliations

    • Departments of Radiology and Nuclear Medicine, Oxford Radcliffe Hospitals NHS Trust, Oxford, UK
    • ,
  • K.M. Bradley

      Affiliations

    • Departments of Radiology and Nuclear Medicine, Oxford Radcliffe Hospitals NHS Trust, Oxford, UK
    • ,
  • F.V. Gleeson

      Affiliations

    • Departments of Radiology and Nuclear Medicine, Oxford Radcliffe Hospitals NHS Trust, Oxford, UK

Received 27 December 2008 ,Revised 16 March 2009 ,Accepted 20 March 2009.

References 

  1. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336:1224–1234
  2. Brincker H, Wilbeck E. The incidence of malignant tumours in patients with respiratory sarcoidosis. Br J Cancer. 1974;29:247–251
  3. Brincker H. Sarcoid reactions in malignant tumours. Cancer Treat Rev. 1986;13:147–156
  4. Brincker H. The sarcoidosis–lymphoma syndrome. Br J Cancer. 1986;54:467–473
  5. Cohen PR, Kurzrock R. Sarcoidosis and malignancy. Clin Dermatol. 2007;25:326–333
  6. Llombart A, Martinez-Escudero J. The incidence and significance of epithelioid and sarcoid-like cellular reaction in the stromata of malignant tumours. A morphological and experimental study. Eur J Cancer. 1970;6:545–551
  7. Parra ER, Canzian M, Ab' Saber AM, et al. Pulmonary and mediastinal “sarcoidosis” following surgical resection of cancer. Pathol Res Prac. 2004;200:701–705
  8. Karapetis CS, Strickland AH, Yip D, et al. PET and PLAP in suspected testicular cancer relapse: beware sarcoidosis. Ann Oncol. 2001;12:1485–1488
  9. Maeda J, Ohta M, Hirabayashi H, et al. False positive accumulation in 18F fluorodeoxyglucose positron emission tomography scan due to sarcoid reaction following induction chemotherapy for lung cancer. Jpn J Thorac Cardiovasc Surg. 2005;53:196–198
  10. Li YJ, Zhang Y, Gao S, et al. Cervical and axillary lymph node sarcoidosis misdiagnosed as lymphoma on F-18 FDG PET-CT. Clin Nucl Med. 2007;32:262–264
  11. Takanami K, Kaneta T, Yamada T, et al. FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports. Clin Nucl Med. 2008;33:258–261
  12. Tangen JM, Naess A, Aasen T, et al. Noncaseating granulomas in patients with hematologic malignancies: a report of three cases. Acta Med Scand. 1988;223:83–87
  13. Asakawa H, Tsuji M, Tokumine Y, et al. Gastric T-cell lymphoma presenting with epithelioid granulomas mimicking tuberculosis in regional lymph nodes. J Gastroenterol. 2001;36:190–194
  14. O'Connell MJ, Schimpff SC, Kirschner RH, et al. Epitheloid granulomas in Hodgkin's disease: a favorable prognostic sign?. JAMA. 1975;233:886–889
  15. Sacks EL, Donalds SS, Gordon J, et al. Epitheloid granulomas associated with Hodgkin's disease: clinical correlations on 55 previously untreated patients. Cancer. 1978;41:562–567
  16. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med. 1994;35:1647–1649
  17. Alavi A. Is there a role for FDG PET imaging in the management of patients with sarcoidosis?. J Nucl Med. 1994;35:1650–1652
  18. Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med. 2006;47:1571–1576
  19. Prabhakar HB, Rabinowitz CB, Gibbons FK, et al. Imaging features of sarcoidosis on MDCT, FDG PET, and PET/CT. AJR Am J Roentgenol. 2008;190:S1–S6
  20. Teirstein AS, Machac J, Almeida O, et al. Results of 188 whole-body fluorodeoxyglucose positron emission scans in 137 patients with sarcoidosis. Chest. 2007;132:1949–1953
  21. Braun JJ, Kessler R, Constantinesco A, et al. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging. 2008;35:1537–1543
  22. Reich JM, O'Connor EA, Brouns MC, et al. Mediastinoscopy in patients with presumptive stage I sarcoidosis: a risk/benefit, cost/benefit analysis. Chest. 1998;113:147–153
  23. Hunsaker AR, Munden RF, Pugatch RD, et al. Sarcoidlike reaction in patients with malignancy. Radiology. 1996;200:255–261
  24. Baldini S, Pupi A, Di Lollo S, et al. PET positivity with bone marrow biopsy revealing sarcoidosis in a patient in whom bone marrow metastases had been suspected. Br J Haematol. 2008;143:306
  25. Karam M, Roberts-Klein S, Shet N, et al. Bilateral hilar foci on 18F-FDG PET scan in patients without lung cancer: variables associated with benign and malignant etiology. J Nucl Med. 2008;49:1429–1436

PII: S0009-9260(09)00124-X

doi: 10.1016/j.crad.2009.03.005

Clinical Radiology
Volume 64, Issue 7 , Pages 675-681 , July 2009

Article Tools

* Image Usage & Resolution